End-of-day quote
Other stock markets
|
||
- USD | - |
15/05 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
15/05 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
Chart calendar Aytu Bioscience Inc
Upcoming events on Aytu Bioscience Inc
Past events on Aytu Bioscience Inc
16/05/2024 02:00 am | Q3 2024 Earnings Call |
15/05/2024 | Q3 2024 Earnings Release After hours |
05/04/2024 02:10 am | Emerging Growth Conference |
15/02/2024 03:00 am | Q2 2024 Earnings Call |
15/02/2024 02:35 am | Q2 2024 Earnings Release |
01/02/2024 10:15 pm | Lytham Partners Investor Select Conference |
07/12/2023 11:40 pm | Emerging Growth Conference |
15/11/2023 03:00 am | Q1 2024 Earnings Call |
15/11/2023 02:35 am | Q1 2024 Earnings Release |
17/10/2023 04:30 pm | Lytham Partners Fall Investor Conference |
04/10/2023 10:30 pm | LD Micro Main Event Conference |
28/09/2023 02:00 am | Q4 2023 Earnings Call |
28/09/2023 01:50 am | Q4 2023 Earnings Release |
22/06/2023 12:30 am | Maxim Group Virtual Healthcare Conference |
18/05/2023 09:30 pm | Annual General Meeting |
12/05/2023 02:00 am | Q3 2023 Earnings Call |
12/05/2023 01:35 am | Q3 2023 Earnings Release |
22/02/2023 03:30 am | Interim 2023 Earnings Call |
22/02/2023 02:40 am | Interim 2023 Earnings Release |
31/01/2023 07:30 pm | Lytham Partners virtual Investor Select Conference |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7,32 7,38 -0.77% | 27,6 24,0 15.01% | 65,6 66,2 -0.78% | 96,7 94,7 2.08% | 107 104 2.91% | 81,3 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -46,8 -21,8 -114.45% | -25,9 -68,3 62.15% | -4,94 -4,35 -13.64% | 9,18 |
EBIT Million USD | Released Forecast Spread | -16,8 -16,7 -0.98% | -20,9 -18,1 -15.89% | -58,9 -45,5 -29.38% | -112 -105 -6.1% | -12,3 -20,4 39.62% | -2,83 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,1 -16,9 -60.57% | -13,6 -17,1 20.18% | -58,0 -50,4 -15.25% | -110 -105 -5.38% | -17,1 -20,7 17.44% | -12,7 |
Net income Million USD | Released Forecast Spread | -27,1 -17,1 -59.06% | -13,6 -15,1 9.53% | -58,3 -50,4 -15.77% | -110 -105 -5.38% | -17,1 -20,7 17.44% | -13,7 |
EPS USD | Released Forecast Spread | -696 -430 -61.86% | -60,0 -44,0 -36.36% | -69,6 -56,8 -22.54% | -75,0 -71,5 -4.9% | -5,11 -6,16 17.05% | -2,49 |
Announcement Date | 26/09/19 | 06/10/20 | 27/09/21 | 27/09/22 | 27/09/23 | - |
Quarterly results
Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 24,2 24,5 -1.23% | 27,4 25,5 7.64% | 27,7 24,3 13.81% | 26,3 29,5 -10.92% | 22,7 27,6 -17.48% | 30,7 27,7 10.97% | 22,1 27,7 -20.3% | 22,9 21,7 5.47% | 18,0 17,3 3.73% | 18,3 |
EBITDA Million USD | Released Forecast Spread | -6,81 -7,50 9.2% | -4,86 -4,00 -21.45% | -2,02 4,60 -143.83% | -6,36 1,20 -630.33% | 4,65 0,09 4948.91% | 0,44 1,65 -73.52% | 5,08 0,35 1352.29% | 0,43 0,50 -14.14% | 1,46 | |
EBIT Million USD | Released Forecast Spread | -54,7 -11,3 -385.82% | -17,9 -11,5 -55.77% | -1,65 -9,00 81.63% | -4,19 -1,70 -146.65% | -8,56 -2,20 -289% | 2,81 -2,68 204.81% | -1,50 1,05 -243.92% | 2,36 -0,09 2726.67% | -2,46 -2,26 -9.03% | -1,23 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -53,1 -11,9 -347.87% | -17,7 -12,1 -46.29% | -2,88 -9,40 69.35% | -6,69 -2,00 -234.65% | -7,20 -2,55 -182.35% | -2,46 -3,88 36.68% | -8,12 -0,24 -3340.68% | 0,61 -1,37 144.35% | -2,64 -3,54 25.39% | -2,51 |
Net income Million USD | Released Forecast Spread | -53,1 -11,9 -347.87% | -17,7 -12,1 -46.29% | -2,88 -9,40 69.35% | -6,69 -2,10 -218.71% | -7,20 -2,55 -182.35% | -2,46 -3,88 36.68% | -8,12 -0,24 -3340.68% | -0,22 -1,37 83.95% | -2,89 -3,54 18.47% | -2,51 |
EPS USD | Released Forecast Spread | -35,8 -8,20 -336.59% | -7,00 -7,40 5.41% | -1,20 -3,60 66.67% | -2,15 -0,70 -207.14% | -1,93 -0,72 -169.93% | -0,59 -0,95 37.89% | -1,48 -0,04 -3600% | -0,04 -0,25 84% | -0,52 -0,64 18.75% | -0,45 |
Announcement Date | 16/05/22 | 27/09/22 | 14/11/22 | 21/02/23 | 11/05/23 | 27/09/23 | 14/11/23 | 14/02/24 | 15/05/24 | - |
30/05/2024 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
30/05/2024 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
04/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
11/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release (Projected) |
16/07/2024 | JOHNSON & JOHNSON: Q2 2024 Earnings Release (Projected) |
16/07/2024 | CAMURUS AB: Q2 2024 Earnings Release |
17/07/2024 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
18/07/2024 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
18/07/2024 10:30 am | NOVARTIS AG: Q2 2024 Earnings Release |
Past sector events for Aytu Bioscience Inc
- Stock Market
- Equities
- AYTU Stock
- AYTU Stock
- Calendar Aytu Bioscience Inc